About us
Thank you for your interest in learning more about The Centre for Clinical Trials.
Dr. Sapra and Dr. Khanna strongly believe that being on the forefront of medical research is an important part of their respective practices. The Centre for Clinical Trials is actively involved in helping bring new medical therapies to the dermatology and plastic surgery fields by participating in a variety of clinical research studies.
What We Do
The Centre for Clinical Trials conducts both original research and clinical trials alongside the pharmaceutical industry with the goal of bringing new treatment options to our patients. Our areas of research include but are not limited to acne, alopecia, eczema, psoriasis, rosacea, toenail fungus, vitiligo, anti-aging, and cosmetic studies.
Information For Patients
For eligible patients, the benefits of participating in a clinical research trial include:
- Access to possible alternative treatments
- Regular health monitoring (expert medical care and attention)
- Knowing that you are taking part in the advancement of medical research
- Taking an active role in your health care
- No cost associated with these investigational treatments
Assurance to our patients:
- The strictest confidentiality and privacy is upheld at all times
- Patients can expect to receive the most comprehensive care and attention from the overseeing physician as well as our highly skilled and knowledgeable clinical trials team
Frequently Asked Questions
What is a clinical trial?
A clinical trial is a research study that investigates a new drug or treatment using human volunteers, intending to add to medical knowledge.
Who can participate in a clinical trial?
Clinical trials have guidelines listed in the protocol outlining who can participate, which are called eligibility criteria. These guidelines are in place to identify appropriate participants and keep them safe. Eligibility criteria are based on characteristics such as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. The research team reviews the eligibility criteria with all patients prior to enrolling them in a clinical trial.
What is informed consent?
Informed consent is the process of learning and understanding all parts of a clinical trial before deciding whether or not to participate. To help someone make this decision, the research team will explain the details of the study and answer any questions. Patients are provided with an informed consent document that outlines all details about the study. Patients are asked to sign the document to indicate their decision to participate or not; however, informed consent is not a contact, meaning a participant can leave the clinical trial at any time.
Can a participant leave a clinical trial after it has begun?
Yes, a participant may leave a clinical trial at any time for any reason. When deciding to leave a clinical trial, let the research team know about the decision and the reasons for leaving.
What is a placebo?
A placebo is an inactive drug or treatment in a clinical trial. Experimental treatments are often compared to placebos to assess the treatment’s effectiveness.
What are the different phases of clinical trials?
There are 4 phases of clinical trials. In phase I trials, the experimental drug or treatment is tested in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosing range, and identify side effects. In phase II trials, the experimental drug or treatment is given to a larger group of people (100-300) to see if it is effective and further evaluate safety. In phase III trials, the experimental drug or treatment is given to large groups of people (1000-3000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect additional safety information. Phase IV trials are conducted after the product is on the market to obtain additional information including the drug’s risks, benefits, and optimal use. The Centre for Clinical Trials conducts trials in phases II, III, and IV.
